[1] Flagg K Y, Karavatas S G, Thompson S Jr, et al. Current criteria for return to play after anterior cruciate ligament reconstruction:An evidence-based literature review[J]. Annals of Translational Medicine, 2019(7):S252.
[2] Glogovac G, Schumaier A P, Grawe B M. Return to sport following revision anterior cruciate ligament reconstruction in athletes:A systematic review[J]. Arthroscopy 2019, 35(7):2222-2230.
[3] Kostyun R O, Burland J P, Kostyun K J, et al. Male and female adolescent athletes' readiness to return to sport after anterior cruciate ligament injury and reconstruction[J]. Clinical Journal of Sport Medicine, 2019, doi:10.1097/jsm.0000000000000751.
[4] Nwachukwu B U, Adjei J, Rauck R C, et al. How much do psychological factors affect lack of return to play after anterior cruciate ligament reconstruction? A systematic review[J]. Orthopaedic Journal of Sports Medicine, 2019, 7(5):2325967119845313.
[5] Della Villa F, Andriolo L, Ricci M, et al. Compliance in post-operative rehabilitation is a key factor for return to sport after revision anterior cruciate ligament reconstruction[J]. Knee Surgery, Sports Traumatology, Arthroscopy, 2019, doi:https://doi.org/10.1007/s00167-019-05649-2.
[6] Kosy J D, Phillips J R P, Edordu A, et al. Failure to return to preinjury activity level after hamstring anterior cruciate ligament reconstruction:Factors involved and considerations in goal setting[J]. Indian Journal of Orthopaedics 2019, 53(6):714-720.
[7] Patel N K, Sabharwal S, Hadley C, et al. Factors affecting return to sport following hamstrings anterior cruciate ligament reconstruction in non-elite athletes[J]. European Journal of Orthopaedic Surgery & Traumatology, 2019(29):1771-1779.
[8] Bodkin S G, Rutherford M H, Diduch D R, et al. How much time is needed between serial "return to play" assessments to achieve clinically important strength gains in patients recovering from anterior cruciate ligament reconstruction[J]. The American Journal of Sports Medicine, 2020, 48(1):70-77.
[9] Hamrin Senorski E, Svantesson E, Beischer S, et al. Low 1-Year return-to-sport rate after anterior cruciate ligament reconstruction regardless of patient and surgical factors:A prospective cohort study of 272 patients[J]. The American Journal of Sports Medicine, 2018, 46(7):1551-1558.
[10] Davies W T, Myer G D, Read P J. Is it time we better understood the tests we are using for return to sport decision making following ACL reconstruction? a critical review of the hop tests[J]. Sports Medicine, 2020, 50:485-495.
[11] Hart H F, Culvenor A G, Guermazi A, et al. The InjuryPsychological Readiness to return to sport (I-PRRS) scale and the Sport Confidence Inventory (SCI):A crosscultural validation[J]. Physical Therapy in Sport, 2019(40):218-224.
[12] Dunlop G, Ardern C L, Andersen T E, et al. Return-to-play practices following hamstring injury:A worldwide survey of 131 premier league football teams[J]. Sports Medicine, 2019, doi:10.1007/s40279-019-01199-2.
[13] Webster K E, Nagelli C V, Hewett T E, et al. Factors associated with psychological readiness to return to sport after anterior cruciate ligament reconstruction surgery[J]. The American Journal of Sports Medicine, 2018, 46(7):1545-1550.
[14] O'Connor R F, King E, Richter C, et al. No relationship between strength and power scores and anterior cruciate ligament return to sport after injury scale 9 months after anterior cruciate ligament reconstruction[J]. The American Journal of Sports Medicine, 2020, 48(1):78-84.
[15] Nagelli C V, Hewett T E. Should return to sport be delayed until 2 years after anterior cruciate ligament reconstruction? Biological and functional considerations[J]. Sports Medicine, 2017, 47(2):221-232.
[16] Willy R W, Hoglund L T, Barton C J, et al. Patellofemoral Pain[J]. Journal of Orthopaedic & Sports Physical Therapy, 2019, 49(9):CPG1-CPG95.
[17] Willy R W, Hoglund L T, Barton C J, et al. Patellofemoral pain:Using the evidence to guide physical therapist practice[J]. Journal of Orthopaedic & Sports Physical Therapy, 2019, 49(9):631-632.
[18] Edwards S G, Calandruccio J H. Autologous blood injections for refractory lateral epicondylitis[J]. Journal of Hand Surgery, 2003, 28(2):272-278.
[19] Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma[J]. American Journal of Sports Medicine, 2006, 34(11):1774-1778.
[20] Mishra A K, Skrepnik N V, Edwards S G, et al. Efficacy of platelet-rich plasma for chronic tennis elbow:A double-blind, prospective, multicenter, randomized controlled trial of 230 patients[J]. The American Journal of Sports Medicine, 2014, 42(2):463-471.
[21] Creaney L, Wallace A, Curtis M, et al. Growth factorbased therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy:A prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections[J]. British Journal of Sports Medicine, 2011, 45(12):966-971.
[22] Thanasas C, Papadimitriou G, Charalambidis C, et al. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis:A randomized controlled clinical trial[J]. The American Journal of Sports Medicine, 2011, 39(10):2130-2134.
[23] Pinar H, Koch M A, Hawkins H, et al. Treatment of achilles tendinopathy with platelet-rich plasma[J]. International Journal of Sports Medicine, 2010, 31(8):577-583.
[24] Owens R F, Jr Ginnetti J, Conti S F, et al. Clinical and magnetic resonance imaging outcomes following platelet rich plasma injection for chronic midsubstance Achilles tendinopathy[J]. Foot & Ankle International, 2011, 32(11):1032-1039.
[25] Volpi P, Quaglia A, Schoenhuber H, et al. Growth factors in the management of sport-inducedtendinopathies:Results after 24 months from treatment. A pilot study[J]. The Journal of Sports Medicine and Physical Fitness, 2010, 50(4):494-500.
[26] Mautner K, Colberg R E, Malanga G, et al. Outcomes after ultrasound-guided platelet-rich plasma injections for chronic tendinopathy:A multicenter, retrospective review[J]. PM&R, 2013, 5(3):169-175.
[27] Creaney L. Platelet-rich plasma for treatment of Achilles tendinopathy[J]. The Journal of the American Medical Association, 2010, 303(17):1696.
[28] Deans V M, Miller A, Ramos J. A prospective series of patients with chronic achilles tendinopathy treated with autologous-conditioned plasma injections combined with exercise and therapeutic ultrasonography[J]. The Journal of Foot and Ankle Surgery, 2012, 51(6):706-710.
[29] Oloff L, Elmi E, Nelson J, et al. Retrospective analysis of the effectiveness of platelet-rich plasma in the treatment of Achilles tendinopathy:Pretreatment and posttreatment correlation of magnetic resonance imaging and clinical assessment[J]. Foot & Ankle Specialist, 2015, 8(6):490-497.
[30] Murawski C D, Smyth N A, Newman H, et al. A single platelet-rich plasma injection for chronic midsubstance achilles tendinopathy:A retrospective preliminary analysis[J]. Foot & Ankle Specialist, 2014, 7(5):372-376.
[31] Ferrero G, Fabbro E, Orlandi D, et al. Ultrasound-guided injection of platelet-rich plasma in chronic Achilles and patellar tendinopathy[J]. Journal of Ultrasound, 2012, 15(4):260-266.
[32] de Vos R J, Weir A, van Schie H T, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy:A randomized controlled trial[J]. The Journal of the American Medical Association, 2010, 303(2):144-149.
[33] Charousset C, Zaoui A, Bellaiche L, et al. Are multiple platelet-rich plasma injections useful for treatment of chronic patellar tendinopathy in athletes? A prospective study[J]. The American Journal of Sports Medicine, 2014, 42(4):906-911.
[34] Kaux J F, Bruyere O, Croisier J L, et al. One-year follow-up of platelet-rich plasma infiltration to treat chronic proximal patellar tendinopathies[J]. Acta Orthopaedica Belgica, 2015(81):251-256.
[35] Bubnov R, Yevseenko V, Semeniv I. Ultrasound guided injections of platelets rich plasma for muscle injury in professional athletes. Comparative study[J]. Medical Ultrasonography, 2013, 15(2):101-105.
[36] Liu B, Cheng H, Ma W, et al. Common variants in the GNL3 contribute to the increasing risk of knee osteoarthritis in Han Chinese population[J]. Scientific Reports, 2018, 8(1):9610.
[37] Evans C H. Advances in regenerative orthopedics[J]. Mayo Clinic Proceedings, 2013, 88(11):1323-1339.
[38] de Bari C, Roelofs A J. Stem cell-based therapeutic strategies for cartilage defects and osteoarthritis[J]. Current Opinion in Pharmacology, 2018, 40:74-80.
[39] Kong L, Zheng L Z, Qin L, et al. Role of mesenchymal stem cells in osteoarthritis treatment[J]. Journal of Orthopaedic Translation, 2017(9):89-103.
[40] Im G I. Tissue engineering in osteoarthritis:Current status and prospect of mesenchymal stem cell therapy[J]. BioDrugs 2018(4), 32:183-192.
[41] Volarevic V, Arsenijevic N, Lukic M L, et al. Concise review:Mesenchymal stem cell treatment of the complications of diabetes mellitus[J]. Stem Cells, 2011, 29(1):5-10.
[42] Emadedin M, Labibzadeh N, Liastani M G, et al. Intraarticular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis:A randomized, triple-blind, placebo-controlled phase 1/2 clinical trial[J]. Cytotherapy, 2018, 20(10):1238-1246.
[43] Davatchi F, Sadeghi Abdollahi B, Mohyeddin M, et al. Mesenchymal stem cell therapy for knee osteoarthritis:5 years follow-up of three patients[J]. International Journal of Rheumatic Diseases, 2016, 19(3):219-225.
[44] Orozco L, Munar A, Soler R, et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells:A pilot study[J]. Transplantation, 2013, 95(12):1535-1541.
[45] Elaheh M, Hamid R M, Maryam M T, et al. Mesenchymal stem cell-derived exosomes:A new therapeutic approach to osteoarthritis[J]. Stem Cell Research & Therapy 2019(10):340.
[46] Marzetti E, Calvani R, Tosato M, et al. Sarcopenia:An overview[J]. Aging Clinical and Experimental Research, 2017(29):11-17.
[47] Yu R, Wong M, Leung J, et al. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults[J]. Geriatrics & Gerontology International, 2014, 14(suppl 1):15-28.
[48] Anker S D, Morley J E, von Haehling S. Welcome to the ICD-10 code for sarcopenia[J]. Journal of Cachexia, Sarcopenia and Muscle, 2016, 7(5):512-514.
[49] Cruz-Jentoft A J, Bahat G, Bauer J, et al. Sarcopenia:Revised European consensus on definition and diagnosis[J]. Age and Ageing, 2019, 48(4):16-31.
